NCAM1 and Miyoshi myopathy: CD20 expression on BMPCs was markedly more frequent in t(11;14)-positive MM (33.3% vs. 3.9%, p < 0.0001), whereas CD56 positivity was significantly reduced (46.7% vs. 77.9%, p = 0.0017).